Native Platelet Function and Clinical Outcomes in Very Elderly Patients: A Retrospective Cohort Study

Area of Science:

• Geriatric Medicine
• Hematology
• Clinical Laboratory Science

Background:

• Platelet function is crucial for hemostasis, but its behavior in the very elderly (≥80 years) without antiplatelet or anticoagulant therapy is not well understood.
• Aging may affect platelet aggregation and contribute to adverse outcomes, necessitating investigation in this specific demographic.

Purpose of the Study:

• To examine native platelet function in very elderly patients (≥80 years) not receiving specific therapies.
• To assess the correlation between platelet function and routine laboratory parameters.
• To identify factors associated with poor 90-day outcomes in this population.

Main Methods:

• Retrospective cohort study of 94 very elderly inpatients (80-89 years and ≥90 years).
• Exclusion of patients on antiplatelet, anticoagulant, or glucocorticoid therapy.
• Measurement of adenosine diphosphate (ADP)- and arachidonic acid (AA)-induced platelet aggregation, platelet count, and collection of 90-day outcome data.

Main Results:

• No significant differences in platelet count or aggregation rates were observed between octogenarians and nonagenarians.
• Platelet function showed no meaningful correlation with white blood cell count, hemoglobin, or fibrinogen.
• No statistically significant predictors for poor 90-day outcomes were identified, with only 13 adverse events observed.

Conclusions:

• Native platelet function is preserved in very elderly individuals and does not correlate with routine hematological parameters.
• The study did not identify significant predictors of poor 90-day outcomes, likely due to limited statistical power from a small number of events.
• Larger prospective studies are recommended to validate these exploratory findings on platelet function and outcomes in the very elderly.